Editorial: Genetics and multi-omics approach in metabolic liver disorders

Omar Ramos-Lopez¹, Prabu Paramasivam², Gautam K Pandey³, Sathishkumar Chandrakumar^{4

5}

Affiliations

¹ Medicine and Psychology School, Autonomous University of Baja California, Tijuana, Baja California, Mexico.
² Department of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico Health Sciences, Albuquerque, NM, United States.
³ Department of Genetics, University of North Carolina, Chapel Hill, NC, United States.
⁴ Department of Ophthalmology, University of California, Los Angeles, Los Angeles, CA, United States.
⁵ Doheny Eye Institute, Pasadena, CA, United States.

PMID: 40496558
PMCID: PMC12148883
DOI: 10.3389/fendo.2025.1620522

Editorial

Editorial: Genetics and multi-omics approach in metabolic liver disorders

Omar Ramos-Lopez et al. Front Endocrinol (Lausanne). 2025.

. 2025 May 27:16:1620522.

doi: 10.3389/fendo.2025.1620522. eCollection 2025.

Authors

Omar Ramos-Lopez¹, Prabu Paramasivam², Gautam K Pandey³, Sathishkumar Chandrakumar^{4

5}

Affiliations

¹ Medicine and Psychology School, Autonomous University of Baja California, Tijuana, Baja California, Mexico.
² Department of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico Health Sciences, Albuquerque, NM, United States.
³ Department of Genetics, University of North Carolina, Chapel Hill, NC, United States.
⁴ Department of Ophthalmology, University of California, Los Angeles, Los Angeles, CA, United States.
⁵ Doheny Eye Institute, Pasadena, CA, United States.

PMID: 40496558
PMCID: PMC12148883
DOI: 10.3389/fendo.2025.1620522

No abstract available

Keywords: NAFLD/MASLD; bioinformatics; genetics; liver disorders; multi-omics; precision medicine.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

Editorial on the Research Topic Genetics and multi-omics approach in metabolic liver disorders

References

1. Devarbhavi H, Asrani SK, Arab JP, Nartey YA, Pose E, Kamath PS. Global burden of liver disease: 2023 update. J Hepatol. (2023) 79:516–37. doi: 10.1016/j.jhep.2023.03.017 - DOI - PubMed
1. Vargas M, Cardoso Toniasso SC, Riedel PG, Baldin CP, Dos Reis FL, Pereira RM, et al. Metabolic disease and the liver: A review. World J Hepatol. (2024) 16:33–40. doi: 10.4254/wjh.v16.i1.33 - DOI - PMC - PubMed
1. Nogueira JP, Cusi K. Role of insulin resistance in the development of nonalcoholic fatty liver disease in people with type 2 diabetes: from bench to patient care. Diabetes Spectr. (2024) 37:20–8. doi: 10.2337/dsi23-0013 - DOI - PMC - PubMed
1. Shi F, Zhao M, Zheng S, Zheng L, Wang H. Advances in genetic variation in metabolism-related fatty liver disease. Front Genet. (2023) :1213916. doi: 10.3389/fgene.2023.1213916 - DOI - PMC - PubMed
1. Ramos-Lopez O. Multi-omics nutritional approaches targeting metabolic-associated fatty liver disease. Genes (Basel). (2022) 13:2142. doi: 10.3390/genes13112142 - DOI - PMC - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Frontiers Media SA
- PubMed Central

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Editorial: Genetics and multi-omics approach in metabolic liver disorders

Affiliations

Editorial: Genetics and multi-omics approach in metabolic liver disorders

Authors

Affiliations

Conflict of interest statement

Comment on

Similar articles

References

Publication types

LinkOut - more resources

Full Text Sources